Nicotine sustains addictive tobacco use, which in turn causes much premature disability and death. The essence of drug addiction is loss of control of drug use. Molecular biology studies suggest that the ␣ 4  2 nicotinic acetylcholine receptor subtype is the main receptor mediating nicotine dependence. Nicotine acts on these brain nicotinic cholinergic receptors to facilitate neurotransmitter release (dopamine and others), producing pleasure, stimulation, and mood modulation. Neuroadaptation develops with repeated exposure to nicotine, resulting in tolerance to many of the effects of nicotine. When a smoker stops smoking, a nicotine withdrawal syndrome ensues, characterized by irritability, anxiety, increased eating, dysphoria, and hedonic dysregulation, among other symptoms. Smoking is also reinforced by conditioning, such that specific stimuli that are psychologically associated with smoking become cues for an urge to smoke. These include the taste and smell of tobacco, as well as particular moods, situations, and environmental cues. Pharmacotherapies to aid smoking cessation should ideally reduce nicotine withdrawal symptoms and block the reinforcing effects of nicotine obtained from smoking without causing excessive adverse effects. Further, given the important role of sensory effects of smoking and psychoactive effects of nicotine, counseling and behavioral therapies are important adjuncts to and substantially augment the benefits of pharmacotherapy. © 2008 Elsevier Inc. All rights reserved.
KEYWORDS:Addiction; Nicotine; ␣ 4  2 Nicotinic Acetylcholine Receptors; Pharmacotherapy; Smoking Use of nicotine sustains tobacco addiction, which in turn causes devastating health problems including heart disease, lung disease, and cancer. Smoking harms almost every organ of the body. 1 Quitting smoking at any age leads to significant reductions in the risks associated with smoking, 1 and the vast majority of smokers in the United States indicate an interest in quitting. 2 Despite these facts, however, approximately 80% of smokers who attempt to quit on their own relapse within the first month of abstinence and only about 3% remain abstinent at 6 months. 3 This illustrates the powerful force of tobacco addiction and the chronic nature of the disorder. Tobacco addiction is best considered a chronic disease, with most smokers requiring repeated interventions over time before achieving permanent abstinence.Although most of the toxicity of smoking is related to other components of the cigarette, it is the pharmacologic effects of nicotine that produce the addiction to tobacco. An understanding of how nicotine produces addiction and influences smoking behavior provides a necessary basis for optimal smoking cessation intervention. 4 This article reviews the neurobiology of nicotine addiction and withdrawal, as well as the implications for nicotine addiction therapy.